PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

Abveris is Boston's premier antibody discovery company providing contract research services to the biopharma industry. Abveris applies advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies to provide comprehensive gene-to-antibody discovery services.
Abzena is a life sciences group with its headquarters in San Diego, California with other sites across the US and Europe. Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry.
AcceGen is a US leading biotechnological company. Founded in 2016, located in Fairfield, New Jersey, AcceGen provides complete and authentic cell products and services.
Accellacare is a global clinical research network increasing patient recruitment and retention with a patient centric approach. Accellacare extends across the globe with 82 active research sites in six countries with expertise in a wide range of therapeutic areas. It has relationships with 275 Principal Investigators connecting it to 8 million+ patients.
Accelsiors delivers strategic solutions for conducting global clinical trials with the ultimate objective of improving public health. We dedicate ourselves to serving the needs of our customers with talented and motivated staff, a commitment to quality, global regulatory experience and expertise and a personal touch.
We're more than a consulting and talent solutions business. We are passionate about providing our clients and candidates with the most effective talent and consulting partnership available in the Life Sciences market. Accenian innovates to stay ahead of our competition so that you can stay ahead of yours.
Our mission is to join the hospitals, pharmacists, wholesalers, and other front-line healthcare providers in the vital delivery of life-sustaining drugs to their patients. We place orders with the highest levels of precision, take personal and mutual responsibility for support needs, and consider the patient's well-being as our primary goal.
Acella Pharmaceuticals, LLC is a specialty pharmaceutical company committed to innovating the healthcare field by bringing quality and affordable products to our customers and patients. Our diverse portfolio of therapeutic products helps patients with a variety of healthcare needs.
ACHIEVA comprises five respected specialist recruitment businesses*1, joining forces to become one stronger and more powerful entity, bolstered by research, development and environmental enterprises that share our core values.
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens: protein markers unique to each individual that are present on the surface of a cancer cell and can be detected by the immune system.
As a Swiss pharmaceutical company headquartered in Zurich, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms. We are a leader in advanced drug delivery technologies with a focus on modified release oral forms, and oral dispersible forms, for which we also hold patents.
We are focused on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel, small molecule therapies to help people impacted by under served immuno-inflammatory conditions. Our team of experienced and accomplished kinome experts use the proprietary KINect® technology platform to generate clinical candidates for difficult to drug kinases with novel approaches.
Acorda’s mission is to develop therapies that restore function and improve the lives of people with neurological disorders.
We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider.
We are at a breakthrough moment for Alzheimer’s disease research and drug development. At Acumen, we are leveraging decades of learnings to deliver treatments that can truly impact everyone affected by this devastating disease.
Ad Idem Consulting is a privately-owned, independent recruitment consultancy delivering permanent, interim and contract positions for Finance, Risk & Operations as well as Project Management professionals to businesses of all sizes.
Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer. Driven by a powerful platform combining computational biology and artificial intelligence, we create novel antibodies that overcome safety issues and improve efficacy to bring hope to more cancer patients.
Adamas is a fully integrated pharmaceutical company experienced in drug discovery, development, and delivery of treatments for neurological diseases. We are driven by a deep sense of purpose – to make everyday life significantly better for people affected by neurological disorders.
We are an immunotherapy company developing an innovative portfolio of therapeutic antibodies designed to modulate the activity of a patient’s own cytotoxic gamma delta T cells in situ. Our exquisitely targeted approach offers the potential to safely and effectively address the challenges often encountered by current cancer immunotherapies.
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company’s unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.